NAS:IART (USA) Also Trade In: Germany

Integra Lifesciences Holdings Corp $ 70.12 0.65 (0.94%)

Volume:
461,962
Avg Vol (1m):
375,230
Market Cap $:
5.92 Bil
Enterprise Value $:
7.10 Bil
PE Ratio:
44.49
PB Ratio:
3.91
Warning! GuruFocus has detected 1 Severe warning sign with IART. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Integra Lifesciences Holdings Corp () from 1995 to Apr 10 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Integra Lifesciences stock (IART) PE ratio as of Apr 10 2021 is 44.49. More Details

Integra Lifesciences PE Ratio (TTM) Chart

EMBED

Integra Lifesciences PE Ratio (TTM) Historical Data

Total 1205
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Integra Lifesciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-04-1044.5 2021-02-0843.9
2021-04-0944.5 2021-02-0543.3
2021-04-0844.1 2021-02-0443.2
2021-04-0743.2 2021-02-0342.2
2021-04-0643.3 2021-02-0242.6
2021-04-0543.3 2021-02-0142.3
2021-04-0243.2 2021-01-2941.9
2021-04-0143.2 2021-01-2843.4
2021-03-3143.8 2021-01-2743.6
2021-03-3043.7 2021-01-2644.3
2021-03-2942.6 2021-01-2544.0
2021-03-2643.7 2021-01-2244.0
2021-03-2542.0 2021-01-2144.0
2021-03-2441.6 2021-01-2044.5
2021-03-2341.5 2021-01-1943.4
2021-03-2242.6 2021-01-1543.0
2021-03-1942.4 2021-01-1443.0
2021-03-1842.2 2021-01-1341.7
2021-03-1743.2 2021-01-1241.5
2021-03-1642.9 2021-01-1141.8
2021-03-1543.5 2021-01-0841.9
2021-03-1243.2 2021-01-0741.8
2021-03-1143.2 2021-01-0640.9
2021-03-1043.5 2021-01-0540.5
2021-03-0942.6 2021-01-0439.7
2021-03-0841.9 2020-12-3141.2
2021-03-0542.0 2020-12-3041.3
2021-03-0441.8 2020-12-2942.2
2021-03-0343.1 2020-12-2842.0
2021-03-0244.0 2020-12-24100.0
2021-03-0144.1 2020-12-2398.7
2021-02-2643.4 2020-12-2297.2
2021-02-2543.9 2020-12-2194.1
2021-02-2444.6 2020-12-1894.5
2021-02-2343.9 2020-12-1793.6
2021-02-2243.7 2020-12-1691.6
2021-02-1943.3 2020-12-1589.8
2021-02-1843.7 2020-12-1486.6
2021-02-1745.2 2020-12-1187.8
2021-02-1644.1 2020-12-1088.8
2021-02-1543.9 2020-12-0985.0
2021-02-1243.9 2020-12-0884.0
2021-02-1144.1 2020-12-0782.9
2021-02-1043.8 2020-12-0484.9
2021-02-0943.8 2020-12-0382.7

Integra Lifesciences PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry
Healthcare » Medical Devices & Instruments » NAICS : 339112 NAICS : 3841
Traded in other countries
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.